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OBJECTIVES The objective of the present study was to determine whether improved contractility after left
ventricular assist device (LVAD) support reflects altered myocyte calcium cycling and changes
in calcium-handling proteins.
BACKGROUND Previous reports demonstrate that LVAD support induces sustained unloading of the heart
with regression of pathologic hypertrophy and improvements in contractile performance.
METHODS In the human myocardium of subjects with heart failure (HF), with non-failing hearts (NF),
and with LVAD-supported failing hearts (HF-LVAD), intracellular calcium ([Ca2]i)
transients were measured in isolated myocytes at 0.5 Hz, and frequency-dependent force
generation was measured in multicellular preparations (trabeculae). Abundance of sarcoplas-
mic reticulum Ca2 adenosine triphosphatase (SERCA), Na/Ca2 exchanger (NCX), and
phospholamban was assessed by Western analysis.
RESULTS Compared with NF myocytes, HF myocytes exhibited a slowed terminal decay of the Ca2
transient (DTterminal, 376  18 ms vs. 270  21 ms, HF vs. NF, p  0.0008), and
HF-LVAD myocytes exhibited a DTterminal that was much shorter than that observed in HF
myocytes (278  10 ms, HF vs. HF-LVAD, p  0.0001). Trabeculae from HF showed a
negative force-frequency relationship, compared with a positive relationship in NF, whereas
a neutral relationship was observed in HF-LVAD. Although decreased SERCA abundance
in HF was not altered by LVAD support, improvements in [Ca2]i transients and
frequency-dependent contractile function were associated with a significant decrease in NCX
abundance and activity from HF to HF-LVAD.
CONCLUSIONS Improvement in rate-dependent contractility in LVAD-supported failing human hearts is
associated with a faster decay of the myocyte calcium transient. These improvements reflect
decreases in NCX abundance and transport capacity without significant changes in SERCA
after LVAD support. Our results suggest that reverse remodeling may involve selective, rather
than global, normalization of the pathologic patterns associated with the failing
heart. (J Am Coll Cardiol 2004;44:837–45) © 2004 by the American College of
Cardiology Foundationr
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Ln laboratory studies of failing human hearts, the most
rominent functional abnormalities observed have been
lowed rates of relaxation and impaired contractile reserve
xemplified by a negative force-frequency response. These
unctional abnormalities, in turn, have been linked to
lterations in calcium cycling and the abundance of key
alcium regulatory proteins such as sarcoplasmic reticulum
alcium adenosine triphosphatase (SERCA), the sarcolem-
al Na/Ca2 exchanger (NCX), and phospholamban
PLB) (1–5). Such studies support the hypothesis that
efects in calcium homeostasis, particularly reduced calcium
From the *Cardiovascular Research Center, Temple University, Philadelphia,
ennsylvania; †North Shore-Long Island Jewish Research Institute, Manhasset, New
ork; ‡Department of Physiology, Loyola University Chicago, Chicago, Illinois; and
Department of Endocrinology, North Shore Hospital Medical Center, Manhasset,
ew York. Supported by grants from the National Institutes of Health, Bethesda,
aryland (HL33921 and HL61495 to Dr. Houser, HL03560 and AG17022 to Dr.
argulies), and the Southeastern Pennsylvania Affiliate of the American Heart
ssociation (0110063U to Dr. Rossman).
Manuscript received January 23, 2003; revised manuscript received April 28, 2004,wccepted May 11, 2004.euptake by the sarcoplasmic reticulum, represent primary
ontributors to the impaired cardiac contractility.
Recent studies demonstrate improved in vitro myocardial
unction in failing human hearts that required mechanical
irculatory support with a left ventricular assist device
LVAD) (6,7). For example, Dipla et al. reported improved
asal relaxation rates and improved frequency-dependent
esponses (6), whereas Heerdt et al. observed an improved
orce-frequency relationship in association with increases in
ERCA protein abundance (7).
To further examine the physiologic mechanisms respon-
ible for improvements in myocardial contractile function
fter LVAD support, we studied whole-cell calcium tran-
ients in isolated cardiac myocytes and performed further
xperiments to relate changes in calcium cycling to changes
n frequency-dependent contractile reserve and the abun-
ance of calcium handling proteins. Our results indicate
hat the prolonged terminal decay of the calcium transient
bserved in myocytes from failing hearts is normalized after
VAD support and that this improvement is associated
ith an improved force-frequency response. Faster intracel-
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Altered Ca2 Cycling With LVAD Support August 18, 2004:837–45ular calcium ([Ca2]i) transient decay was also associated
ith functionally significant reductions in NCX protein
bundance although SERCA abundance did not change
ignificantly with LVAD support. These studies indicate
hat improved myocyte relaxation and contractile reserve
fter LVAD support reflect a change in the functional
alance between SERCA and the NCX for [Ca2]i
euptake.
ETHODS
ubjects and tissue preparation. Human left ventricular
LV) myocardial tissue was obtained at the time of cardiac
ransplantation from 27 patients with severe heart failure
HF) and from 15 patients who required LVAD support
efore cardiac transplantation (HF-LVAD). Left ventricu-
ar tissue was also obtained from 18 non-failing hearts (NF)
f brain-dead organ donors that could not be used for
ransplantation. Temple University Institutional Review
oard approved the studies on explanted heart tissue.
All hearts were arrested in situ with cold, blood-
ontaining, cardioplegia solution and promptly transported
o the laboratory in Krebs-Henseleit buffer (KHB) solution
s previously described (6). The right ventricle (RV) of the
eart was removed for preparation of isolated trabeculae. An
picardial vessel supplying the LV free wall was cannulated
or perfusion digestion, and transmural samples were ob-
ained from viable LV free wall myocardium adjacent to the
egion of perfusion. Tissue slices were immediately snap
rozen in liquid nitrogen and stored at 80°C.
yocyte isolation and volume measurement. After car-
iectomy, a perfusion-based myocyte dissociation procedure
as initiated as previously described (6,8). Myocytes were
esuspended in 1% w/v bovine serum albumin, 10 mM taurine,
nd 0.25 mM CaCl2). All solutions were equilibrated with
5% O2 and 5% CO2. Initial yields of rod-shaped myocytes
anged from 10% to 60% in calcium-containing buffer. An
liquot of freshly isolated myocytes was fixed in an iso-osmotic
olution of 1.5% glutaraldehyde and enriched by Ficoll gradi-
Abbreviations and Acronyms
[Ca2]i  intracellular calcium
HF  heart failure
HF-LVAD  failing hearts supported by a left
ventricular assist device
INCX  Ni
-sensitive inward current
KHB  Krebs-Henseleit buffer
LV  left ventricle/ventricular
LVAD  left ventricular assist device
NCX  sodium-calcium exchanger
NF  non-failing
PLB  phospholamban
RV  right ventricle/ventricular
SERCA  sarcoplasmic reticulum calcium adenosine
triphosphatasent centrifugation as described by Gerdes et al. (9). Median 1yocyte volume for each cell suspension was determined using
Coulter Channelyzer technique as previously described (9).
yocyte intracellular Ca2 measurements. A stock solu-
ion of Fluo-3AM was prepared using Pluronic F-127 (20%
/v in dimethyl sulfoxide) (Molecular Probes, Eugene,
regon). A 1-ml aliquot of myocytes in resuspension buffer
as incubated with Fluo-3AM at a final concentration of
.4 M. Myocytes were studied in a chamber on the stage
f an inverted microscope (Nikon Eclipse TE300); super-
used at 1 to 2 ml/min with Tyrode solution (150 mM
aCl, 5.4 mM KCl, 1 mM CaCl2, 1.2 mM MgCl, 10 mM
lucose, 2 mM pyruvate, 5 mM HEPES, pH 7.4, 37°C).
od-shaped myocytes were chosen on the basis of the
bsence of spontaneous contractions in 1 mM Ca2. Fluo-
AM was excited at 480 nm with a xenon lamp, and the
mitted light at 530 nm was recorded to represent the
ytosolic Ca2 transient ([Ca2]i). Intracellular calcium
easurement was represented as a pseudo-ratio as previ-
usly described (10). Myocytes were field stimulated at a
ate of 0.5 Hz, and [Ca2]i was stored on computer for
nalysis using pClamp software (Axon Instruments, Union
ity, California). Indicated parameters were measured on
hree consecutive transients from each cell (see “Results”).
rotein extraction. Frozen heart tissue (150 mg) was
ulverized by mortar and pestle cooled in liquid nitrogen
nd then homogenized using a Brinkman Polytron for 10 s
n 1.5 ml of homogenization buffer containing 30 mM
ris-HCl pH 7.6, 2 mM ethylenediaminetetraacetic acid,
.6 M NaCl; leupeptin, aprotonin, antipain at 10 g/ml; 1
M phenylmethylsulfonyl fluoride, 2.5 mM benzamidine
nd phosphatase inhibitor cocktail (Sigma, St. Louis, Mis-
ouri). Triton X-100 was added to 0.5% v/v, and the
omogenate was rocked in the cold room for 30 min. An
liquot of homogenate was diluted six-fold with the homog-
nization buffer to a final salt concentration of 0.1 M NaCl
nd centrifuged at 10,000  g for 20 min at 4°C. The
upernatant was collected, and the protein concentration
as determined by Lowry assay.
nalysis of calcium-handling proteins. Tissues homoge-
ization, protein extraction, and electrophoresis were per-
ormed as previously described (11). The proteins (5 or 30
g) were resolved by electrophoresis on either 15% or 10%
odium dodecyl sulfate-polyacrylamide gels for immunoblot
nalysis of PLB and SERCA2 or NCX, respectively.
estern blot analysis was performed and analyzed as
reviously described (11). Antibody dilutions and sources
ere as follows: 1:1,000 for SERCA antibody (Affinity
ioReagents Inc., Golden, Colorado), and 1:1,000 for
ouse monoclonal anti-Na/Ca2 exchanger (Research
iagnostics Inc., Flanders, New Jersey). The NCX anti-
ody recognizes the 120-kDa mature protein and a 70-kDa
roteolytic fragment as well as a 160-kDa form of NCX that
s believed to be either an unreduced product of or an
nprocessed form of the protein. Values for total NCX
rotein abundance are expressed as the summation of the
20-kDa and 70-kDa NCX protein bands quantified from
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August 18, 2004:837–45 Altered Ca2 Cycling With LVAD Supportestern blots. Monoclonal anti-PLB antibody was used at
.05 g/ml and has been shown to recognize both phos-
horylated and dephosphorylated forms of the protein.
ssessment of NCX current. In freshly isolated myocytes
oaded with Fluo-3, whole cell patch clamp recordings were
erformed at 37°C using 1 to 4 mega ohm pipettes as
escribed previously. In the presence of Cesium (in/out) to
lock potassium currents and thapsigargan to block calcium
euptake by the sarcoplasmic reticulum, a voltage-ramp (67
V/s) from 100 mV to 130 mV was employed to
ncrease cytosolic free calcium. After this loading procedure,
he Ni-sensitive inward current was measured following a
apid return to the resting membrane potential as a bioassay
or NCX transport capacity. Simultaneously, [Ca2]i was
easured with Fluo-3 as described above.
uscle strip preparation and force-frequency experi-
ents. The excised cardiac apex was placed in KHB
olution containing 20 mM 2,3-butanedione monoxime and
.25 mM CaCl2 gassed with 95% O2-5% CO2. Thin (500
m), non-branching, free-running trabeculae from the RV
ree wall were carefully removed with a small cube of tissue
n either side and mounted in a tissue bath as previously
escribed (12,13). The KHB solution was replaced by
,3-butanedione monoxime-free KHB solution, and the
ath CaCl2 was increased stepwise from 0.5 to 1.75 mM
ver 15 min. Trabeculae were equilibrated, and muscle
ength was set at 80% Lmax [0.8  (Lmax  Lo)], as
reviously described (14). After an additional 30-min equil-
bration period, steady-state twitches were established (0.5
z, 37°C, 1.75 mM Ca2), and the frequency of stimula-
ion was increased sequentially from 0.5 Hz to 1.0 Hz, 1.5
z, 2.0 Hz, and 2.5 Hz.
tatistical analysis. All data are expressed as mean 
EM. Comparisons between the three experimental groups
Table 1. Clinical Characteristics of Patients
Age Gender LV
NF (n  10) 57  2 10 M
8 F
HF (n  32) 56  2 27 M
6 F
HF-LVAD (n  15) 52  3 11 M
4 F
ACE  angiotensin-converting enzyme inhibitor; Amio
beta-blocker; CCB  calcium channel blocker; Dig  digox
 heart failure group; HF-LVAD  left ventricular assist d
 left ventricular ejection fraction; Mil  milrinone; N/A ere made using one-way analysis of variance for indepen- (ent groups. For intergroup comparisons, Tukey post hoc
nalysis was used to locate the significantly different means.
p value of 0.05 was considered statistically significant
or all hypothesis testing.
ESULTS
linical characteristics. The clinical characteristics of the
F patients are presented in Table 1. Ages of the patients
n the three experimental groups did not differ significantly.
ifteen of the 32 failing hearts without LVAD support and
of the 15 patients with LVAD support had coronary artery
isease and ischemic cardiomyopathy, whereas the balance
ad a nonischemic etiology for failure. The duration of
linical HF before transplantation varied widely among
ailing hearts, but the average duration was similar in
atients with and without LVAD support. In contrast, the
umber of cardiovascular medications being taken at the
ime of transplantation was far greater in the non-LVAD
ailing hearts.
yocyte volume. Myocyte volume measurements revealed
arked cellular hypertrophy in the failing hearts. Myocytes
rom HF hearts (n 11) were an average of 35% larger than
yocytes from NF hearts (n 7) (NF 32,210 2,469 m3
s. HF 50,025  3,438 m3; p  0.01). The LVAD
upport was associated with a significant decrease in myo-
yte volume, with myocytes an average of 26% larger in HF
earts than in cells from HF-LVAD hearts (n  7)
HF-LVAD 36,933  4,511 m3; HF-LVAD vs. HF p 
.01). The LVAD-supported and NF myocytes were not
ignificantly different.
yocyte calcium transients. Calcium transients (0.5 Hz,
mM Ca2, 37°C) were recorded in 20 HF myocytes, 5 NF
yocytes, and 15 HF-LVAD myocytes. The time constant
2
(%) Etiology Medications
3 N/A Dopa 7/18, CCB 1/18,
ARB 1/18, BB 2/18,
Nit 1/18
1 13 Idio
15 Isch
4 Other
Dob 22/32, Mil 20/32,
Dig 26/32, Diu 25/32,
Nit 14/32, ACE 26/32,
ARB 15/32, Amio 10/32,
CCB 4/32, BB 6/32
9 Idio
6 Isch
Dob 2/15, Mil 3/15,
Dig 3/15, Diu 4/15,
Nit 2/15, ACE 3/15,
ARB 2/15, Amio 4/15,
CCB 2/15
iodarone; ARB  angiotensin receptor blocker; BB 
iu  diuretic; Dob  dobutamine; Dopa  dopamine; HF
upported group; Idio  idiopathic; Isch  ischemic; LVEF
applicable; NF  non-failing group; Nit  nitrate.EF
57 
13 
N/A
 am
in; D
evice s) for the initial portion of the [Ca ]i decay (DTinitial) was
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Altered Ca2 Cycling With LVAD Support August 18, 2004:837–45easured by fitting a mono-exponential curve to each
ransient beginning at 150 ms after the peak and continuing
or 200 ms. The terminal portion of the [Ca2]i decay
DTterminal) was described by fitting a mono-exponential
urve beginning at the point where Ca2 had fallen to 75%
f its peak and ending at the start of the next stimulus
arker (Fig. 1B). Data from the three experimental groups
re presented in Figure 1C. Although the peak [Ca2]i level
id not differ between the three experimental groups (data
ot shown), there were inter-group differences in the
Ca2]i decay. The DTinitial tended to be longer in HF
yocytes than in NF and HF-LVAD myocytes (HF 263
0 ms; NF 163  13 ms; HF-LVAD 175  17 ms; HF vs.
F p  0.11; HF vs. HF-LVAD p  0.06). For the
Tterminal, there were striking differences, with the HF
able 2. Summary of Western Blot Protein Abundance and
yocyte Morphometry
NF
(n  12)
HF
(n  12)
HF-LVAD
(n  8)
LB 5.27  1.01 5.40  0.93 6.20  1.42
ERCA2a 6.27  0.56 3.03  0.6‡ 3.54  0.66†
ERCA2a/PLB ratio 1.94 0.55 0.68  0.11* 0.66  0.13*
CX 5.14  0.68 12.92  1.78‡ 8.56  1.11*§
ERCA/NCX ratio 1.48 0.22 0.30  0.07‡ 0.49  0.16†
p  0.05, †p  0.01, ‡p  0.001 versus NF; §p  0.08 versus HF. Values are mean
SEM.
NCX  Na/Ca2 exchanger; PLB  phospholamban; SERCA  sarcoplasmic
eticulum calcium adenosine triphosphatase; SERCA2a  SERCA type 2a. Other
igure 1. Effects of left ventricular assist device (LVAD) support on [Ca2
VAD support. Data were collected during field stimulation at 0.5 Hz, an
races from representative myocytes. (B) Schematic illustrating curve-fittin
verage initial and delayed time constants for the [Ca2]i transients in each
LVAD support). Data are expressed as mean  SEM. *p  0.0001 Hbbreviations as in Table 1. fyocytes significantly prolonged compared with both the
F and the HF-LVAD myocytes (HF 376  18 ms, NF
70  21 ms, HF-LVAD 278  10 ms; HF vs. NF, p 
.0008; HF vs. HF-LVAD, p  0.0001). Thus, sustained
VAD support is associated with increases in the rate of
Ca2]i transient decay in failing human myocytes.
alcium regulatory protein abundance. The abundance
f key calcium regulatory proteins, SERCA, PLB, and
CX, in each of the three experimental groups is presented
n Table 2 and Figure 2. We observed highly significant
ecreases in SERCA protein abundance in both the HF and
F-LVAD patient groups compared with the NF group.
lthough no significant differences were observed in PLB
rotein abundance among the groups, the SERCA/PLB
atio in the HF and LVAD patients was reduced by 2.9-fold
p 0.05) compared with the NF patient group. Moreover,
nsients in cardiac myocytes from failing hearts with and without previous
2]i was measured by Fluo-3 fluorescence. (A) Raw fluorescence intensity
nique for initial and delayed portions of the [Ca2]i transient decay. (C)
e three experimental groups (NF non-failing; HF failing; HF-LVAD
y versus HF-LVAD; †p  0.001.
igure 2. Western blot demonstrating protein abundance for sarcoplasmic
eticulum calcium adenosine triphosphatase (SERCA2), sodium-calcium
xchanger (NCX), and phospholamban (PLB). NF  non-failing; HF ]i tra
d [Ca
g tech
of th
F-onlailing; LVAD  left ventricular assist device support.
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August 18, 2004:837–45 Altered Ca2 Cycling With LVAD Supporthe abundance of the NCX protein was 2.5-fold higher in
F than in NF but was only 50% greater in LVAD-
upported hearts than in NF hearts. Nevertheless, in both
F and HF-LVAD hearts the SERCA/NCX protein ratio
as significantly reduced compared with NF.
CX transport capacity. As described, we examined the
unctional significance of the decrease in NCX protein
bundance after LVAD support. Data from these experi-
ents (Fig. 3) demonstrate that HF-LVAD myocytes
xhibit decreased forward-mode Ni-sensitive inward cur-
ent (INCX) compared with HF myocytes across a wide
ange of intracellular Ca2 levels. These findings suggest
hat functionally significant reductions in NCX transport
apacity are associated with decreased NCX protein abun-
ance in LVAD-supported hearts.
orce-frequency experiments. Figure 4 and Table 3 show
epresentative raw data tracings and twitch parameters during
rogressive increases in stimulation frequency. Under basal
onditions (0.5 Hz), RV trabeculae from NF hearts exhibited
elatively low developed tension, rate of force development
dF/dt), and rate of relaxation (dF/dt). With increasing
timulation frequencies, we observed a positive force-frequency
elationship in the NF trabeculae, a negative force-frequency
elationship in the HF trabeculae, and an intermediate re-
ponse in the HF-LVAD trabeculae. At the highest stimula-
ion frequency, dF/dt and dF/dt were equivalent in NF
nd HF-LVAD trabeculae and considerably greater than rates
igure 3. Assessment of forward-mode sodium-calcium exchanger transp
revious left ventricular assist device (LVAD) support. (A) Schematic
ytosolic-free calcium (see “Methods”). (B) The Ni-sensitive inward curre
verage data are depicted from failing myocytes with and without previous
ata are expressed as mean  SEM.bserved in HF trabeculae. pISCUSSION
he principal finding of this investigation is that the decay
n myocyte [Ca2]i transient is prolonged in failing myo-
ytes compared with non-failing myocytes and that LVAD
upport of the failing heart is associated with a faster decay
f the [Ca2]i transient. These changes in the [Ca
2]i decay
re associated with partial restoration of the abnormal
orce-frequency relationship observed in failing hearts. As in
everal previous studies, we observed that functional abnor-
alities in calcium cycling and rate-dependent contractile
eserve in HF are associated with decreases in SERCA and
ncreases in NCX abundance. However, the observed func-
ional improvements after LVAD support occurred in the
bsence of increased SERCA abundance and were associ-
ted with only partial, though functionally significant,
ecreases in NCX abundance. These findings suggest that
lterations in cardiac myocyte [Ca2]i homeostasis repre-
ent a mechanism for previously reported improvements in
yocardial relaxation and defects in the force-frequency
esponse after LVAD support, but they do not exclude
ossible contributions of other factors, including myofila-
ent Ca2 sensitivity, action potential duration, and intra-
ellular sodium.
rolonged Ca2 transients in failing myocytes. One of
he hallmarks of a failing human heart is an impairment of
elaxation that is manifested as abnormal diastolic filling
pacity in isolated cardiac myocytes from failing hearts with and without
ration of the voltage-ramp (67 mV/s) protocol employed to increase
CX) is plotted as a function of [Ca
2]i after membrane repolarization. (C)
D support (n  31, n 10). HF failing; HF-LVAD LVAD support.ort ca
illust
nt (IN
LVAatterns, and prolonged relaxation times in isolated myo-
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Altered Ca2 Cycling With LVAD Support August 18, 2004:837–45ytes and muscle strips. In the few studies that have
easured calcium transients in failing human myocytes,
rolongation of the [Ca2]i transient has been closely
ssociated with prolongation of cellular relaxation (6,15–
7). Several of these studies have also observed variability in
he shape of the “failing” [Ca2]i transient, including an
nitial followed by a delayed decline in cytosolic Ca2 levels
16–18). Using a previously published approach that de-
cribes [Ca2]i transient decay with two separate time
onstants (initial and terminal) (19–21), we were able to
aithfully model the transients observed in our isolated
yocytes. We observed that the time constants for the
igure 4. Force generation by isolated right ventricular trabeculae from non
epresentative force transients at low stimulation frequency (0.5 Hz) show
on-failing muscles. *p  0.05 NF versus HF and HF-LVAD. (B) Represe
eveloped force in non-failing and LVAD-supported trabeculae compared
ata ( SEM) in which developed force is plotted as a function of stimu
elationship is seen in non-failing myocardium, a clearly negative force-
orce-frequency relationship is seen after LVAD support.
able 3. Twitch Parameters From Isolated Trabeculae
0.5 Hz
NF
(n  10)
HF
(n  10)
H
(
evT 11.9  1.6*§ 22.9  2.8 20
dF/dt 91.1  15.5‡ 202.0  16.1 154
dF/dt 73.6  12.5† 143.9  13.4 106
p  0.05, †p  0.01, ‡p  0.001 NF versus HF; §p  0.05 NF versus HF-LVAD
DevT  developed tension; dF/dt  maximal force rise; dF/dt  maximal force dnitial (p  0.11) and terminal (p  0.0008) portions of the
ecay of the [Ca2]i transient were prolonged in HF versus
F myocytes. These findings are consistent with previous
tudies in failing human myocytes as well as several animal
odels of HF (15,22–25). Our laboratory has previously
eported that the initial portion of the contraction and
yocyte [Ca2]i transient of failing human myocytes is
ensitive to sarcoplasmic reticulum calcium depletion and is
rimarily under the control of SERCA transport. On the
ther hand, the terminal portion of the [Ca2]i transient
ecay, which is dependent on the timing of repolarization,
s more likely to reflect the combined actions of SERCA-
ng, failing, and left ventricular assist device (LVAD)-supported hearts. (A)
igher developed force in failing and LVAD-supported trabeculae than in
e force transients at high stimulation frequencies (2.5 Hz) showing higher
unsupported failing trabeculae. †p  0.05 NF versus HF. (C) Averaged
frequency in each of the three groups. A clearly positive force-frequency
ncy relationship is seen in unsupported failing myocardium, and a flat
2.5 Hz
AD
5)
NF
(n  10)
HF
(n  10)
HF-LVAD
(n  15)
2.6 25.7  4.0 15.2  2.0* 21.9  3.6
17.5 282.0  56.2 147.5  16.7* 280.3  55.9
12.3 200.8  42.7 105.7  15.3* 192.2  36.5
0.05 HF versus HF-LVAD. Values are mean  SEM.-faili
ing h
ntativ
with
lation
frequeF-LV
n  1
.6 
.8 
.0 
; p 
ecline. Other abbreviations as in Table 1.
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outward Ca2 transport) (26).
In this context, the prolonged early decay of the [Ca2]i
ransient in failing myocytes is consistent with both the
ecrease in SERCA and the increase in NCX abundance
hat we observed, compared with non-failing myocytes. The
rolonged terminal decay of the [Ca2]i transient in failing
yocytes is more consistent with the reduced SERCA
bundance and activity than the increase in NCX protein
bundance because the latter would tend to accelerate the
erminal decay of the [Ca2]i transient, all other things
eing equal. This dominant action of SERCA-mediated
Ca2]i transport during terminal portions of the [Ca
2]i
ransient is consistent with recent studies examining the
uantitative contributions of SERCA and NCX to de-
reases in cytosolic [Ca2]i in failing human myocytes: 69%
ERCA versus 31% NCX (27). However, action potential
rolongation in failing myocardium may also delay calcium
xtrusion via the voltage-sensitive NCX transport (17).
aster Ca2 transient decay after LVAD support. Previ-
us studies have shown increases in the rates of in vitro
yocardial relaxation in isolated myocytes (6) and isolated
uscle strips (28,29) from LVAD-supported hearts com-
ared with non-supported control hearts. Though we and
thers (6,28) have hypothesized that LVAD-induced alter-
tions in Ca2 homeostasis might contribute to contractile
mprovements, the present study is the first to directly
easure [Ca2]i transients in adequate numbers of LVAD-
upported human myocytes. We observed a faster decay of
oth the early (p  0.08) and especially the late (p 
.0001) components of the [Ca2]i transient in the LVAD-
upported myocytes, with no significant differences observed
etween myocytes from HF-LVAD and NF hearts. In our
tudies, the faster initial decay of the [Ca2]i in HF-LVAD
yocytes was not associated with significant increases in
ERCA protein abundance and SERCA/PLB ratio. How-
ver, our analysis does not preclude the possibility that an
ltered phosphorylation state of PLB and the ryanodine
eceptor after LVAD support might have contributed to the
hasic [Ca2]i decay rates (30). An alternative hypothesis is
hat reduced reverse-mode Na/Ca exchange, the increased
ERCA/NCX ratio, and perhaps greater sarcoplasmic re-
iculum Ca2 loading are responsible for the faster early
ecay of [Ca2]i. Indeed, the functional significance of the
VAD-associated decrease in NCX protein abundance was
ffirmed by our INCX bioassay, indicating that NCX trans-
ort capacity was decreased in LVAD-supported myocytes
ndependent of the timing of repolarization or sarcoplasmic
eticulum function.
LVAD-associated increases in the rate of [Ca2]i decay
ere particularly consistent for the terminal portions of the
ransient. In general, the reductions in NCX transport
apacity that we observed with LVAD support would have
een expected to slow, rather than accelerate, the rate of
erminal [Ca2]i decay. Accordingly, likely contributors to
he faster terminal decay actually observed in myocytes after aVAD support include shortening of the action potential
uration, as we have previously observed (30), and possibly
normalization of the elevated [Na]i recently reported in
ailing myocardium (31). Both changes would tend to favor
faster [Ca2]i decay and a decrease in reverse-mode
a/Ca exchange. A shorter action potential duration would
dditionally promote better synchrony of SERCA-mediated
Ca2]i reuptake and NCX-mediated [Ca
2]i extrusion
ith a faster terminal [Ca2]i decay even in the presence of
n absolute decrease in NCX transport capacity. In addition,
e cannot exclude a functional contribution of the non-
ignificant increase in SERCA protein abundance that we
bserved after LVAD support, or an increase in SERCA
ransport activity.
mproved frequency-dependent responses after LVAD
upport. An important characteristic of the failing heart is
decrease in contractile reserve upon increased rate of
timulation. To evaluate the impact of changes in intracel-
ular Ca2 handling on contractile reserve, we employed
solated trabeculae from NF, HF, and HF-LVAD-
upported hearts. At slow stimulation frequencies, we ob-
erved intact contractile performance in failing trabeculae.
owever, in contrast to the positive force-frequency re-
ponse in the NF trabeculae, we observed a negative
orce-frequency response in the failing trabeculae consistent
ith previous reports (2–5,31–35). Trabeculae from
VAD-supported hearts demonstrated an improved force-
requency response compared with failing hearts. In addi-
ion, rates of force generation and decline increased in NF
nd HF-LVAD myocardium as stimulation frequency in-
reased, contrary to HF myocardium. Overall, these find-
ngs confirm and extend previous studies in isolated LV
yocytes (6) and studies in RV trabeculae after LVAD
upport (28).
Previous reports suggested that the negative force-
requency response in failing human hearts is a reflection of
n alteration in the normal functional balance between
ERCA and the NCX. Thus, increased dependency on the
elatively slower NCX transport mechanism for the decay of
he Ca2 transport leads to reduced resequestration of Ca2
nto the sarcoplasmic reticulum during faster stimulation
requencies and a negative force-frequency response. In this
ontext, our findings suggest that an isolated decrease in
CX protein abundance and transport capacity tends to
meliorate the negative force-frequency response by restor-
ng a more favorable balance between SERCA and NCX,
ven without restoration of SERCA protein abundance to
evels observed in NF hearts.
Finally, Pieske et al. have observed that [Na]i is elevated
n muscle strips from failing human hearts, which promotes
he maintenance of sarcoplasmic reticulum calcium load at
ow pacing rates (36). It is tempting to speculate that a
eduction in the functional capacity of NCX after LVAD
upport along with a hypothetical decrease in [Na]i would
urther promote sarcoplasmic reticulum calcium uptake and
positive force-frequency relationship.
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Altered Ca2 Cycling With LVAD Support August 18, 2004:837–45tudy limitations. Myocyte studies are confounded by
solation procedure, regional variability in myocytes, and
ifferences in disease as well as patient medications. In an
ffort to minimize variability in our myocyte preparations,
e have employed an established, high-yield isolation pro-
ocol that is uniform for the different types of tissue studied.
rabeculae were isolated from the RV of the same hearts,
nd these multicellular preparations obviate some concerns
bout the isolation procedure while allowing more realistic
easures of contractility in loaded preparations. Although
ur isolated trabeculae were from the RV, our studies
uggest that the underlying pathology in the RV is similar to
hat reported in the LV. An advantage in using RV
rabeculae is that this region is largely spared from infarction
nd ischemia. As in all studies employing human heart
issue, availability of control tissue is a challenge. Because
ruly “normal” tissue is rarely available, we use the termi-
ology “non-failing” when describing control tissue. Indeed,
he physiology and molecular characterization of this NF
issue does reflect what we assume to be normal based on
nimal studies, such as a positive force-frequency relation-
hip and a rapid relaxation phase of both the calcium
ransient and force development. Because of practical limi-
ations, not all assays were performed on all hearts. Never-
heless, for each functional and molecular assay, sufficient
umbers of tissues from the appropriate groups were studied
o ensure meaningful results.
onclusion. Implantation of an LVAD removes, in part,
he pathologic stimulus for hypertrophy caused by chronic
emodynamic overload of the failing heart (37). Our data
how that functional improvement after LVAD support
ccurred without increases in SERCA and was associated
ith limited, but functionally significant, decreases in NCX.
n isolated decrease in NCX restores a more favorable
alance between SERCA and NCX, even without increases
n SERCA. On a more general level, our findings also
uggest that myocardial adaptations, including improved
ontractile responses, induced by LVAD support or other
nterventions, may involve selective, rather than global,
ormalization of the pathologic patterns associated with the
ailing heart.
eprint requests and correspondence: Dr. Kenneth B. Margulies,
ssociate Professor of Medicine and Physiology, Cardiovascular
esearch Center, Temple University School of Medicine, Room 805
RB, 3420 North Broad Street, Philadelphia, Pennsylvania 19140.
-mail: margul@temple.edu.
EFERENCES
1. Mishra S, Gupta RC, Tiwari N, Sharov VG, Sabbah HN. Molecular
mechanisms of reduced sarcoplasmic reticulum Ca(2) uptake in
human failing left ventricular myocardium. J Heart Lung Transplant
2002;21:366–73.
2. Schillinger W, Lehnart SE, Prestle J, et al. Influence of SR Ca(2)-
ATPase and Na()-Ca(2)-exchanger on the force-frequency rela-
tion. Basic Res Cardiol 1998;93:38–45.3. Pieske B, Maier LS, Bers DM, Hasenfuss G. Ca2 handling and
sarcoplasmic reticulum Ca2 content in isolated failing and nonfailing
human myocardium. Circ Res 1999;85:38–46.
4. Hasenfuss G, Reinecke H, Studer R, et al. Relation between myocar-
dial function and expression of sarcoplasmic reticulum Ca(2)-
ATPase in failing and nonfailing human myocardium. Circ Res
1994;75:434–42.
5. Hasenfuss G, Schillinger W, Lehnart SE, et al. Relationship between
Na-Ca2-exchanger protein levels and diastolic function of failing
human myocardium. Circulation 1999;99:641–8.
6. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB.
Myocyte recovery after mechanical circulatory support in humans with
end-stage heart failure. Circulation 1998;97:2316–22.
7. Heerdt PM, Holmes JW, Cai B, et al. Chronic unloading by left
ventricular assist device reverses contractile dysfunction and alters gene
expression in end-stage heart failure. Circulation 2000;102:2713–9.
8. Zafeiridis A, Jeevanandam V, Houser SR, Margulies KB. Regression
of cellular hypertrophy after left ventricular assist device support.
Circulation 1998;98:656–62.
9. Gerdes AM, Moore JA, Hines JM, Kirkland PA, Bishop SP. Regional
differences in myocyte size in normal rat heart. Anatom Record
1986;215:420–6.
0. Takahashi A, Camacho P, Lechleiter JD, Herman B. Measurement of
intracellular calcium. Physiol Rev 1999;79:1089–125.
1. Shenoy R, Klein I, Ojamaa K. Differential regulation of SR calcium
transporters by thyroid hormone in rat atria and ventricles. Am J
Physiol Heart Circ Physiol 2001;281:H1690–6.
2. Janssen PM, Lehnart SE, Prestle J, et al. The trabecula culture system:
a novel technique to study contractile parameters over a multiday time
period. Am J Physiol 1998;274:H1481–8.
3. Janssen PM, Lehnart SE, Prestle J, Hasenfuss G. Preservation of
contractile characteristics of human myocardium in multi-day cell
culture. J Mol Cell Cardiol 1999;31:1419–27.
4. Rossman EI, Petre RE, Chaudhary KW, et al. Abnormal frequency-
dependent responses represent the pathophysiologic signature of
contractile failure in human myocardium. J Mol Cell Cardiol 2004;36:
33–42.
5. Beuckelmann DJ. Contributions of Ca(2)-influx via the L-type
Ca(2)-current and Ca(2)-release from the sarcoplasmic reticulum
to [Ca2]i-transients in human myocytes. Basic Res Cardiol 1997;
92:105–10.
6. Dipla K, Mattiello JA, Margulies KB, Jeevanandam V, Houser SR.
The sarcoplasmic reticulum and the Na/Ca2 exchanger both
contribute to the Ca2 transient of failing human ventricular myo-
cytes. Circ Res 1999;84:435–44.
7. Gaughan JP, Furukawa S, Jeevanandam V, et al. Sodium/calcium
exchange contributes to contraction and relaxation in failed human
ventricular myocytes. Am J Physiol 1999;277:H714–24.
8. Mattiello JA, Margulies KB, Jeevanandam V, Houser SR. Contribution
of reverse-mode sodium-calcium exchange to contractions in failing
human left ventricular myocytes. Cardiovasc Res 1998;37:424–31.
9. Bers DM, Lederer WJ, Berlin JR. Intracellular Ca transients in rat
cardiac myocytes: role of Na-Ca exchange in excitation-contraction
coupling. Am J Physiol 1990;258:C944–54.
0. Bers DM, Berlin JR. Kinetics of [Ca]i decline in cardiac myocytes
depend on peak [Ca]i. Am J Physiol 1995;268:C271–7.
1. Hobai IA, O’Rourke B. Enhanced Ca(2)-activated Na()-Ca(2)
exchange activity in canine pacing-induced heart failure. Circ Res
2000;87:690–8.
2. Lindner M, Erdmann E, Beuckelmann DJ. Calcium content of the
sarcoplasmic reticulum in isolated ventricular myocytes from patients
with terminal heart failure. J Mol Cell Cardiol 1998;30:743–9.
3. Beuckelmann DJ, Nabauer M, Kruger C, Erdmann E. Altered
diastolic [Ca2]i handling in human ventricular myocytes from
patients with terminal heart failure. Am Heart J 1995;129:684–9.
4. Gomez AM, Guatimosim S, Dilly KW, Vassort G, Lederer WJ.
Heart failure after myocardial infarction: altered excitation-contraction
coupling. Circulation 2001;104:688–93.
5. Bailey BA, Dipla K, Li S, Houser SR. Cellular basis of contractile
derangements of hypertrophied feline ventricular myocytes. J Mol Cell
Cardiol 1997;29:1823–35.
22
2
2
3
3
3
3
3
3
3
3
845JACC Vol. 44, No. 4, 2004 Chaudhary et al.
August 18, 2004:837–45 Altered Ca2 Cycling With LVAD Support6. Yao A, Matsui H, Spitzer KW, Bridge JH, Barry WH. Sarcoplasmic
reticulum and Na/Ca2 exchanger function during early and late
relaxation in ventricular myocytes. Am J Physiol 1997;273:H2765–73.
7. Piacentino 3rd, V Weber CR, Chen X, et al. Cellular basis of
abnormal calcium transients of failing human ventricular myocytes.
Circ Res 2003;92:651–8.
8. Barbone A, Holmes JW, Heerdt PM, et al. Comparison of right and left
ventricular responses to left ventricular assist device support in patients
with severe heart failure: a primary role of mechanical unloading under-
lying reverse remodeling. Circulation 2001;104:670–5.
9. Ogletree-Hughes ML, Stull LB, Sweet WE, Smedira NG, McCarthy
PM, Moravec CS. Mechanical unloading restores beta-adrenergic
responsiveness and reverses receptor downregulation in the failing
human heart. Circulation 2001;104:881–6.
0. Currie S, Smith GL. Enhanced phosphorylation of phospholamban
and downregulation of sarco/endoplasmic reticulum Ca2 ATPase
type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with
heart failure. Cardiovasc Res 1999;41:135–46.
1. Hasenfuss G, Reinecke H, Studer R, et al. Calcium cycling proteins
and force-frequency relationship in heart failure. Basic Res Cardiol
1996;91:17–22.2. Pieske B, Kretschmann B, Meyer M, et al. Alterations in intracellular
calcium handling associated with the inverse force-frequency relation
in human dilated cardiomyopathy. Circulation 1995;92:1169–78.
3. Pieske B, Sutterlin M, Schmidt-Schweda S, et al. Diminished post-
rest potentiation of contractile force in human dilated cardiomyopathy:
functional evidence for alterations in intracellular Ca2 handling.
J Clin Invest 1996;98:764–76.
4. Schlotthauer K, Schattmann J, Bers DM, et al. Frequency-dependent
changes in contribution of SR Ca2 to Ca2 transients in failing
human myocardium assessed with ryanodine. J Mol Cell Cardiol
1998;30:1285–94.
5. Alpert NR, Hasenfuss G, Leavitt BJ, Ittleman FP, Pieske B, Mulieri
LA. A mechanistic analysis of reduced mechanical performance in
human heart failure. Jpn Heart J 2000;41:103–15.
6. Pieske B, Maier LS, Piacentino 3rd, V Weisser J, Hasenfuss G,
Houser S. Rate dependence of [Na]i and contractility in nonfailing
and failing human myocardium. Circulation 2002;106:447–53.
7. Sadoshima J, Izumo S. The cellular and molecular response of
cardiac myocytes to mechanical stress. Ann Rev Physiol 1997;59:551–
71.
